SCHEMBL130109

SCHEMBL130109

CCC(C)C[NH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327498 1.00
Hydrochloric Acid SCHEMBL10488451 0.96
SCHEMBL3832547 0.83
SCHEMBL10002814 0.79
SCHEMBL7654 0.74
SCHEMBL7755370 0.74 TSHR (0.46)
SCHEMBL6656924 0.72 TSHR (0.32)
SCHEMBL104639 0.72
SCHEMBL17310158 0.72
SCHEMBL102409 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109923108-B Pyridyl-substituted indole compounds 百时美施贵宝公司 2022-04-29 CN claimed
CN-104974109-B Propine amide derivatives and its preparation method and pharmaceutical composition and purposes containing thiazole 中国医学科学院药物研究所 2019-10-01 CN claimed
CN-104974104-A Propynamide derivatives containing oxazole as well as preparation method, drug composition and application thereof INST MATERIA MEDICA CAMS 2015-10-14 CN claimed
CN-104974109-A Propynamide derivatives containing thiazole as well as preparation method, drug composition and application thereof INST MATERIA MEDICA CAMS 2015-10-14 CN claimed
US-20110269781-A1 COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-11-03 US claimed
US-7977344-B2 Compounds GLAXOSMITHKLINE LLC (US) 2011-07-12 US claimed
EP-2125792-A1 PURINE DERIVATIVES AS IMMUNOMODULATORS Smithkline Beecham Corporation (US) 2009-12-02 EP claimed
WO-2009129371-A1 CATHEPSIN C INHIBITORS GLAXO GROUP LIMITED (GB) 2009-10-22 WO claimed
US-20090264499-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US claimed
US-20090131458-A1 Compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-05-21 US claimed
US-6617324-B1 Phenyl, cyclohexyl and pyridinyl or pyrimidinyl-substituted G. D. SEARLE & COMPANY 2003-09-09 US claimed
WO-2003066630-A2 QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS AMGEN INC. (US) 2003-08-14 WO claimed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US claimed
US-6423713-B1 Substituted pyrazoles as p38 kinase inhibitors G. D. SEARLE & COMPANY 2002-07-23 US claimed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 EP claimed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 WO claimed
EP-1000055-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. Searle & Co. (US) 2000-05-17 EP claimed
EP-0582790-B1 Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines AMERICAN CYANAMID CO (US) 1998-12-23 EP claimed
WO-1998052940-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE AND CO. (US) 1998-11-26 WO claimed
EP-0297816-A2 Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents PFIZER INC. (US) 1989-01-04 EP claimed